(*) CA; EU & JP OK: 2018
(*) USA Approval Date: 2017. 12.05.
>GLP-1 Agonist Injection
Company
Generic Name: Semaglutide
GLP: Glucagon Like Peptide
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 5
Patent>UpDate: 2021. 11.23.
RTM
RTM Web-Site